A note to our patients: Our hearts go out to those most impacted by this virus, and we stand in solidarity with everyone navigating through this challenging and uncertain period. While the majority of our workforce is now sheltering in place, we at MyoKardia continue to work remotely to advance the treatment of cardiomyopathies.
To change the world for people with serious cardiovascular diseases through bold and innovative science, we’re pioneering a precision medicine approach to treating cardiomyopathies and other forms of heart failure that results from biomechanical defects in cardiac muscle contraction.
Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1
Preclinical
Preclinical
Accounting
Marketing
Quality Assurance
Feb 11, 2020
Feb 07, 2020
Jan 28, 2020
Life at MyoKardia
Select CONTINUE for information about Myokardia.
Select BMS to learn more about Bristol Myers Squibb.